Imaging of myocardial fibrosis in hypertrophic cardiomyopathy: what is the gold standard?

Affiliations

Editorial

Bogdan A Popescu et al. Heart. 2014 Apr.

. 2014 Apr;100(8):605-6.

doi: 10.1136/heartjnl-2013-305359. Epub 2014 Jan 23.

¹ Department of Cardiology, University of Medicine and Pharmacy 'Carol Davila', Euroecolab, Institute of Cardiovascular Diseases, , Bucharest, Romania.

No abstract available

Comment on

Noninvasive assessment of myocardial fibrosis in patients with obstructive hypertrophic cardiomyopathy.
Almaas VM, Haugaa KH, Strøm EH, Scott H, Smith HJ, Dahl CP, Geiran OR, Endresen K, Aakhus S, Amlie JP, Edvardsen T. Almaas VM, et al. Heart. 2014 Apr;100(8):631-8. doi: 10.1136/heartjnl-2013-304923. Epub 2013 Dec 24. Heart. 2014. PMID: 24368281

Left atrial dysfunction as a determinant of pulmonary hypertension in patients with severe aortic stenosis and preserved left ventricular ejection fraction.
Calin A, Mateescu AD, Rosca M, Beladan CC, Enache R, Botezatu S, Cosei I, Calin C, Simion M, Ginghina C, Popescu AC, Popescu BA. Calin A, et al. Int J Cardiovasc Imaging. 2017 Dec;33(12):1939-1947. doi: 10.1007/s10554-017-1211-2. Epub 2017 Jul 15. Int J Cardiovasc Imaging. 2017. PMID: 28712069
Functional significance of myocardial activity at ¹⁸F-FAPI PET/CT in hypertrophic cardiomyopathy identified by cardiac magnetic resonance feature-tracking strain analysis.
Zhang Y, Dong Z, Wang L, Wang YL, Chen BX, Su Y, Zhao S, Yang MF. Zhang Y, et al. Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):110-122. doi: 10.1007/s00259-023-06411-0. Epub 2023 Aug 29. Eur J Nucl Med Mol Imaging. 2023. PMID: 37642705